BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1700611)

  • 1. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
    Marcus DM; Minkovitz JB; Wardwell SD; Albert DM
    Am J Ophthalmol; 1990 Nov; 110(5):527-34. PubMed ID: 1700611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR values in Callender histopathological types of malignant uveal melanomas.
    Mera M
    Rom J Morphol Embryol; 1995; 41(3-4):125-8. PubMed ID: 8772368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
    Moshari A; McLean IW
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
    Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar organizer regions in conjunctival nevi and melanomata.
    Koren R; Rath-Wolfson L; Appel I; Pe'er J; Paz A; Klein T; Klein B; Mishaeli M; Gal R
    Oncol Rep; 1998; 5(5):1079-81. PubMed ID: 9683812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal melanoma in children and adolescents.
    Barr CC; McLean IW; Zimmerman LE
    Arch Ophthalmol; 1981 Dec; 99(12):2133-6. PubMed ID: 7305710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study.
    Rummelt V; Folberg R; Rummelt C; Gruman LM; Hwang T; Woolson RF; Yi H; Naumann GO
    Ophthalmology; 1994 Apr; 101(4):718-27. PubMed ID: 8152768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized histologic assessment of malignant potential: a method for determining the prognosis of uveal melanomas.
    Gamel JW; McLean IW; Greenberg RA; Zimmerman LE; Lichtenstein SJ
    Hum Pathol; 1982 Oct; 13(10):893-7. PubMed ID: 7129406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression in uveal malignant melanomas.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinically useful method for combining gross and microscopic measurements to select high-risk patients after enucleation for ciliochoroidal melanoma.
    Gamel JW; Greenberg RA; McLean IW; Seddon JM; Albert DM; Naids RE; Folberg R; Donoso LA
    Cancer; 1986 Apr; 57(7):1341-4. PubMed ID: 2418937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis.
    Tuccari G; Giménez-Mas JA; Fedele F; Del-Agua C; Melcon B; Trombetta CJ; Giuffrè G
    Anal Cell Pathol; 1999; 19(3-4):163-8. PubMed ID: 10866278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
    Kujala E; Kivelä T
    Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
    Fallowfield ME; Cook MG
    Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin.
    Gamel JW; McLean I; Greenberg RA; Naids RM; Folberg R; Donoso LA; Seddon JM; Albert DM
    Hum Pathol; 1985 Jul; 16(7):689-92. PubMed ID: 2408986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.